Literature DB >> 11922702

Clinical characteristics of dural arteriovenous fistula.

Myoung Soo Kim1, Dae Hee Han, O-Ki Kwon, Chang-Wan Oh, Moon Hee Han.   

Abstract

Intracranial dural arteriovenous fistula (DAVF) is an uncommon neurosurgical condition; in particular, it has been infrequently reported in Korea. To understand the general clinical characteristics of DAVFs, the authors reviewed 53 cases and analyzed factors affecting DAVF hemorrhage of and treatment outcome. Since 1980 we have encountered 480 pial and 53 DAVFs, a ratio of 9.1 to 1. The age of these patients ranged from 1 month to 71 years, the most common being in the 6th decade, and females exceeded males by 1.65 to 1. All lesions except three were single, and symptoms were related to location and the venous drainage pattern. The most common location was the cavernous sinus, accounting for about 64% of cases, with the result that the most common clinical symptoms of DAVFs were ocular, namely proptosis and chemosis. The next was tinnitus also found in transverse-sigmoid sinus DAVFs. Intracranial hemorrhage was seen in eight cases,(15%) the primary cause of hemorrhage was retrograde intracranial venous drainage (P=0.017), and one hemorrhage was observed in cases with no intracranial venous drainage. Intracranial hemorrhage was more frequently in transverse-sigmoid than cavernous sinus DAVFs (P=0.049), and this proved to be so even where there was intracranial venous drainage. However, two of 34 patients with cavernous DAVFs became blind in one eye, demonstrating that in such patients, the clinical course could be aggressive. Thirteen patients were treated conservatively. The conservative treatment group was comprised of 13 patients, two of three patients with transverse-sigmoid sinus DAVF expired, and 7 of 10 with cavernous sinus DAVF experienced a clinical improvement or cure. Surgical excision was performed in only two patients. A total of 39 patients underwent embolization; clinical cure was achieved in 13, improvement of symptoms in 12, an unchanged or aggravated result occurred in 9, one died, and four were lost to follow up. During intervention, there was one hemorrhagic complication, owing to obstruction of the venous outflow with embolic materials. In this study, the most common location of DAVFs was the cavernous sinus. The cortical venous drainage remains the primary determinant of intracranial hemorrhage. Common indications for treatment include hemorrhage and neurological deficit. Endovascular treatment is preferred in the majority of cases except tentorial DAVF. The goal of embolization in cavernous DAVF is the alleviation of symptoms, not angiographic cure. But transverse-sigmoid sinus DAVF with venous restriction and leptomeningeal drainage should be treated aggressively. Copyright 2002, Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2002        PMID: 11922702     DOI: 10.1054/jocn.2001.1029

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  32 in total

1.  Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management.

Authors:  D J Kim; D I Kim; S H Suh; J Kim; S K Lee; E Y Kim; T S Chung
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

2.  Pulsatile tinnitus with a dural arterio-venous fistula diagnosed by computed tomography-angiography.

Authors:  Sujin Kim; Jaeyong Byun; Moonsuh Park; Sunkyu Lee
Journal:  Korean J Audiol       Date:  2013-12-13

Review 3.  [Diagnosis and therapy of dural arteriovenous fistulas].

Authors:  W Reith; J Viera; I Q Grunwald; P Papanagiotou
Journal:  Radiologe       Date:  2007-10       Impact factor: 0.635

4.  Diagnostic accuracy of CTA and MRI/MRA in the evaluation of the cortical venous reflux in the intracranial dural arteriovenous fistula DAVF.

Authors:  Yen-Heng Lin; Yu-Fen Wang; Hon-Man Liu; Chung-Wei Lee; Ya-Fang Chen; Hong-Jen Hsieh
Journal:  Neuroradiology       Date:  2017-11-30       Impact factor: 2.804

5.  Carotid duplex sonography in the follow-up of intracranial dural arteriovenous fistulae.

Authors:  Li-Kai Tsai; Hon-Man Liu; Chien-Jung Lu; Jiann-Shing Jeng; Ping-Keung Yip
Journal:  AJNR Am J Neuroradiol       Date:  2005-03       Impact factor: 3.825

6.  Long-term outcome in patients treated for benign dural arteriovenous fistulas of the posterior fossa.

Authors:  Andrea Bink; Joachim Berkefeld; Lubov Kraus; Christian Senft; Ulf Ziemann; Richard du Mesnil de Rochemont
Journal:  Neuroradiology       Date:  2010-08-25       Impact factor: 2.804

Review 7.  Intracranial Dural Arteriovenous Fistulae.

Authors:  Matthew R Reynolds; Giuseppe Lanzino; Gregory J Zipfel
Journal:  Stroke       Date:  2017-05       Impact factor: 7.914

8.  Incidental discovery of a dural arteriovenous fistula in a patient with activated protein C resistance.

Authors:  Jason D Wenderoth; Constantine C Phatouros
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

9.  Endovascular management of dural arteriovenous fistulas of the transverse and sigmoid sinus in 150 patients.

Authors:  M Kirsch; T Liebig; D Kühne; H Henkes
Journal:  Neuroradiology       Date:  2009-04-08       Impact factor: 2.804

10.  Management of dural carotid cavernous fistulas: a single-centre experience.

Authors:  Tiago Rodrigues; Robert Willinsky; Ronit Agid; Karel TerBrugge; Timo Krings
Journal:  Eur Radiol       Date:  2014-07-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.